Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

Discover the molecular mechanisms behind severe blood clots linked to specific COVID-19 vaccines, revealing crucial insights for future vaccine safety.

Verdict comes after petitions filed by Rachana Gangu and others alleged that two women lost their lives in 2021 after taking the first dose of the Covishield vaccine ...

A commission said the country is still grappling with the long-term consequences of both the pandemic and the policy response ...

Five former employees of The MITRE Corporation have taken the company to federal court over its COVID-19 vaccine mandate, ...

By HealthDay Staff HealthDay ReporterMONDAY, March 9, 2026 (HealthDay News) — Dr. Vinay Prasad, who leads the U.S. Food and ...

A public health expert breaks down the most important public health issues on the agenda for the CDC's vaccine advisory ...

The Dutch health council is recommending that the age for the annual coronavirus vaccine is raised from 60 to 70 and older from the coming autumn. The number of infections, hospital admissions and ...

The End the Vaccine Carveout Act would expose vaccine makers to lawsuits that once drove companies out of the industry.

The Covid-19 Royal Commission has broadly backed the decisions taken during the pandemic, while identifying areas for improvement.

The company’s co-founders said they are leaving to start a new mRNA-based company.

Photo credit:RNZ Getting Covid-19 repeatedly puts people at risk of serious health damage, a public health expert is warning ...